News from the BioRN Cluster

Home  >>  News from the BioRN Cluster

EMBL: Visualization of inflammasome formation in real life

On September 21, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL: Visualization of inflammasome formation in real life

Fish On Fire ASC specks (in red) initiate reactions that result in cell death. PHOTO: EMBL/Leptin Group While immune sensing mechanisms vary widely between animals, ASC specks – particles that play a key role in triggering inflammation – form in humans as well as zebrafish. In a study published in…

Heidelberg University: How Blood Vessels Are Formed

On September 19, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: How Blood Vessels Are Formed

Heidelberg scientists gain new insights into the development of the vascular system New insights into the development of the vascular system: researchers in the team of Dr Carmen Ruiz de Almodóvar of the Heidelberg University Biochemistry Center have discovered a crucial biological step that regulates the formation of blood vessels….

Boehringer Ingelheim: Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments

On September 19, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Boehringer Ingelheim: Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments

Obesity affects more than half a billion people worldwide and is a leading risk factor for some of the biggest global drivers of morbidity and mortality, such as  heart disease, stroke and type 2 diabetes1 The new research and development program complements other Boehringer Ingelheim programs that could potentially be…

Heidelberg University: Radioactive Metal Complexes for Tumour Diagnosis and Therapy

On September 14, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Heidelberg University: Radioactive Metal Complexes for Tumour Diagnosis and Therapy

Chemists investigate indium and actinium compounds to develop radiopharmaceuticals Graphics: Miriam Starke, Peter Comba A team under the direction of chemist Prof. Dr Peter Comba is investigating radioactive metal complexes for use in the diagnosis and treatment of tumours. In their recent studies at Heidelberg University’s Institute of Inorganic Chemistry,…

Heidelberg University/DKFZ: Maximum Precision in Protein Synthesis

On September 8, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University/DKFZ: Maximum Precision in Protein Synthesis

Universität Heidelberg research team studies function of molecular folding helpers Researchers from the Center for Molecular Biology of Heidelberg University (ZMBH) and the German Cancer Research Center (DKFZ) have investigated the mode of action of a molecular chaperone vital to protein synthesis. Together with colleagues from the University of Cologne…

TU Kaiserslautern: 1 Mio Euro for new research center for lipidomics

On September 8, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für TU Kaiserslautern: 1 Mio Euro for new research center for lipidomics

Neues Forschungszentrum: Eine Million Euro für die Lipid-Forschung an der TU Kaiserslautern Professor Keller geht im neuen Forschungszentrum der Rolle von Lipiden auf den Grund. Foto: Thomas Koziel/TUK 13 Arbeitsgruppen der TUK sind an dem neuen Forschungszentrum beteiligt. Foto: Thomas Koziel/TUK Welche Rolle spielen Lipide bei Krankheiten wie Alzheimer? Welche…

European Vaccine Initiative:European support for rapidly advancing vaccine development

On September 6, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für European Vaccine Initiative:European support for rapidly advancing vaccine development

TRANSVAC2: Funding for European vaccine research infrastructure | European Vaccine Initiative The European Commission (EC), in the context of the Horizon 2020 Framework Programme, commits significant funding to TRANSVAC2, a European vaccine research and development (R&D) infrastructure. Vaccines are one of the most successful and cost-effective public health tools for…

Fraunhofer IGB: Spray drying – Perfect dosing thanks to drug capsules

On September 1, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Fraunhofer IGB: Spray drying – Perfect dosing thanks to drug capsules

Instant coffee and powdered milk are produced by spray drying. Fraunhofer researchers have adapted this technique to the tricky question of incorporating insoluble substances in core-shell particles. The new method helps reduce the concentration of active ingredients in therapeutic medications. Encapsulation is used in cosmetics and pharmaceuticals to protect active…

Boehringer Ingelheim: FDA approval for CyltezoTM (adalimumab-adbm), a biosimilar to Humira®, for the treatment of multiple chronic inflammatory diseases

On September 1, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Boehringer Ingelheim: FDA approval for CyltezoTM (adalimumab-adbm), a biosimilar to Humira®, for the treatment of multiple chronic inflammatory diseases

CyltezoTM is the first biosimilar from Boehringer Ingelheim to be approved by the FDA, building on 35 years of biologics manufacturing expertise  Robust analytical, pharmacological, non-clinical and clinical data demonstrates that CyltezoTM is biosimilar to Humira®*  Ingelheim, Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that…

EMBL: German state and federal governments agree on funding for a high-resolution microscopy centre in Heidelberg

On September 1, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL: German state and federal governments agree on funding for a high-resolution microscopy centre in Heidelberg

New centre for light and electron microscopy will unite cutting-edge equipment, experts and data analysis The German state and federal governments have agreed on funding for a high-resolution microscopy centre at EMBL in Heidelberg. The letter of intent was signed today during an official ceremony at EMBL’s Heidelberg campus, by…

Merck: European Commission Grants Approval for Mavenclad (Cladribine Tablets) for the treatment of highly active relapsing multiple sclerosis

On August 29, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Merck: European Commission Grants Approval for Mavenclad (Cladribine Tablets) for the treatment of highly active relapsing multiple sclerosis

Merck today announced that the European Commission (EC) has granted marketing authorization for MAVENCLAD® 10mg (Cladribine Tablets) for the treatment of highly active relapsing multiple sclerosis (RMS). 25 AUG 2017 | Darmstadt, Germany First oral short-course treatment for highly active relapsing multiple sclerosis (RMS) now approved in Europe Mavenclad has…

DKFZ: Chaos in cell division – How chromosomal defects arise in cancer cells

On August 23, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Chaos in cell division – How chromosomal defects arise in cancer cells

Cancer cells often have aberrant numbers of chromosomes. Scientists from the German Cancer Research Center have now discovered a new mechanism that plays a role in these typical chromosomal aberrations. The new findings question the current concept of how cancer cells survive the chaos during cell division. This might also…

DKFZ: Using barcodes to trace cell development

On August 17, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Using barcodes to trace cell development

There are various concepts about how blood cells develop. However, they are based almost exclusively on experiments that solely reflect snapshots. In a publication in Nature, scientists from the German Cancer Research Center in Heidelberg now present a novel technique that captures the process in a dynamic way. Using a…

Heidelberg University: Ruperto Carola Again Best German University in Shanghai Ranking

On August 15, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: Ruperto Carola Again Best German University in Shanghai Ranking

University moves up five places to rank 42nd worldwide – and 11th in Europe Top again in Germany! The Shanghai Ranking for 2017, i.e. the Academic Ranking of World Universities, today revealed that Heidelberg University is again the best university in Germany, for the fourth successive time after 2014, 2015…

EMBLEM: AbbVie Germany and EMBL announce new collaboration to better understand Alzheimer’s disease mechanism

On August 14, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBLEM: AbbVie Germany and EMBL announce new collaboration to better understand Alzheimer’s disease mechanism

HEIDLBERG and LUDWIGSHAFEN, August 14, 2017 – AbbVie Germany, a local affiliate of a global biopharmaceutical company and the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory in life sciences, today announced a 2-year collaboration in the field of neurosciences with the aim to advance research and discovery in Alzheimer’s…

DKFZ: Therapies for older leukemia patients

On August 8, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für DKFZ: Therapies for older leukemia patients

The German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) will provide funding for a new research group at the German Cancer Research Center (DKFZ) and at the University of Freiburg and Freiburg University Medical Center. The scientists will jointly pursue fundamental and clinical research into acute myeloid leukemia (AML). The DFG will…

DKFZ: Cancer cells put the brakes on immune system

On August 8, 2017, Posted by , In News,Press Releases, With Kommentare deaktiviert für DKFZ: Cancer cells put the brakes on immune system

In order for cancer cells to successfully spread and multiply, they must find a way to avoid the body’s own immune system. Scientists at the German Cancer Research Center (DKFZ) have published an explanation for how this occurs with chronic lymphatic leukemia (CLL). The degenerated cells cause an inflammatory reaction…

New England Biolabs partners with EMBL

On August 8, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für New England Biolabs partners with EMBL

Collaboration aims to strengthen training opportunities in the latest technologies for young researchers EMBL welcomes New England Biolabs (NEB) as the newest member of the EMBL Advanced Training Centre (ATC) Corporate Partnership Programme. Together, EMBL and NEB will collaborate to develop workshops and training opportunities in new areas of research….

UK Biobank partners with the EGA

On Juli 21, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für UK Biobank partners with the EGA

Genetic data from the UK Biobank’s major cohort is now distributed through the European Genome–phenome Archive (EGA), ensuring its sustainable, secure delivery to approved biomedical researchers worldwide. Genomic data from the 500,000 people participating in the UK Biobank initiative will be distributed via the European Genome–phenome Archive (EGA), a resource…

DKFZ: Surprising genetic variety in childhood brain cancer

On Juli 20, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Surprising genetic variety in childhood brain cancer

An international research team led by scientists from the German Cancer Research Center (DKFZ) and the Hopp Children’s Tumor Center at the NCT Heidelberg (KiTZ) has identified new genetic alterations and mechanisms that lead to very aggressive types of childhood brain cancer. Their results, which have now been published in…